AXT Inc (NAS:AXTI)
$ 88.58 +13.46 (+17.91%) Market Cap: 5.80 Bil Enterprise Value: 5.53 Bil PE Ratio: 4,429.00 PB Ratio: 6.56 GF Score: 61/100

Q2 2026 AXT Inc Earnings Call Transcript

Jul 30, 2026 / 08:30PM GMT
Release Date Price: $46.94 (+26.97%)

Key Points

Positve
  • Record Q2 2026 revenue of $47.6 million, up 77% sequentially and 164% year-over-year, driven by indium phosphide sales for AI data centers.
  • Non-GAAP gross margin surged to 45.0% from 29.9% in Q1, reflecting improved product mix and higher volumes.
  • Returned to profitability with non-GAAP net income of $11.9 million ($0.19 per share), a significant turnaround from losses in prior quarters.
  • Signed strategic long-term supply agreements with Casella, Coherent, and Lumentum, including prepayments of $22.3 million and $25.4 million, securing future revenue.
  • Indium phosphide capacity expansion is ahead of schedule, with revenue opportunity expected to more than triple by end of 2026 and double again in 2027.
  • Backlog exceeds $100 million and continues to grow, with customer demand outpacing supply, providing strong visibility into 2027.
  • Strong progress in 6-inch indium phosphide substrate development, positioning for higher-value products and future growth.
  • China revenue for indium phosphide lasers more than doubled in Q2, with continued strong growth expected in Q3.
  • Cash position strengthened to $748.8 million following a secondary offering, providing ample liquidity for expansion and potential redemptions.
  • Gross margin guidance suggests further improvement, with management targeting a number beginning with '5' as volumes and mix improve.
Negative
  • Export permits for shipping products out of China remain unpredictable, creating uncertainty for revenue timing and recognition.
  • Customer demand continues to outpace supply, limiting the company's ability to accept all orders and potentially constraining near-term revenue growth.
  • The shift of Tongmei's IPO from the STAR market to the Hong Kong Exchange creates a redemption right for PE investors, though they currently intend to continue.
  • Operating expenses increased to $10.2 million (non-GAAP) in Q2, up from $8.6 million in Q1, reflecting higher costs associated with growth.
  • Inventory levels rose by $6.2 million to $96.3 million, indicating potential working capital strain or slower turnover in some product lines.
  • Gross margin improvement is partially dependent on favorable product mix and volume absorption, which could be impacted by future capacity additions and depreciation costs.
  • The company faces intense competition in the indium phosphide market, though it believes it is well-positioned to expand capacity.
  • Geopolitical tensions and trade tariffs could affect the company's ability to export products and increase costs.
  • The company's reliance on a few key customers for a significant portion of revenue (top five customers ~30%) poses concentration risk.
  • Guidance for Q3 includes a high degree of confidence in $66 million revenue, but upside is contingent on receiving additional export permits, which are uncertain.
Operator

Good afternoon, everyone, and welcome to AXT's second quarter 2026 financial conference call.

Leading the call today is Dr. Morris Young, Chief Executive Officer and Gary Fisher, Chief Financial Officer.

In addition, Tim Bettles, VP of Business Development, will be participating in the Q&A portion of the call.

My name is Kenneth, and I will be your coordinator today.

I would now like to turn the call over to Leslie Green, Investor Relations for AXT.

Leslie Green
AXT Inc - Investor Relations

Thank you, Kenneth, and good afternoon, everyone. Before we begin, I would like to remind you that during the course of this conference call, including comments made in response to your questions, we will provide projections or make other forward-looking statements regarding, among other things, the future financial performance of the company, market conditions and trends, emerging applications using chips or devices fabricated on our substrates, our product mix, global economic. Political conditions, including trade tariffs and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot